BMA Fundamental Analysis - BANCO MACRO SA-ADR

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to BMA. BMA was compared to 395 industry peers in the Banks industry. Both the profitability and financial health of BMA have multiple concerns. BMA is valued quite expensively, but it does show have an excellent growth rating.

Quickly go to:

1. Profitability

1.1 Basic Checks

Each year in the past 5 years BMA has been profitable.

In multiple years BMA reported negative operating cash flow during the last 5 years.

1.2 Ratios

BMA has a better Return On Assets (4.49%) than 99.75% of its industry peers.

BMA has a better Return On Equity (16.07%) than 94.43% of its industry peers.

		Industry Rank	Sector Rank
ROA	4.49%
ROE	16.07%
ROIC	N/A

ROA(3y)4.26%

ROA(5y)3.73%

ROE(3y)14.74%

ROE(5y)14.41%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin of BMA (9.66%) is worse than 84.05% of its industry peers.

BMA's Profit Margin has declined in the last couple of years.

BMA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	9.66%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-22.24%

PM growth 5Y-22.5%

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, BMA has about the same amount of shares outstanding.

BMA has less shares outstanding than it did 5 years ago.

BMA has a better debt/assets ratio than last year.

2.2 Solvency

BMA has a debt to FCF ratio of 5.90. This is a neutral value as BMA would need 5.90 years to pay back of all of its debts.

BMA's Debt to FCF ratio of 5.90 is on the low side compared to the rest of the industry. BMA is outperformed by 72.41% of its industry peers.

A Debt/Equity ratio of 0.12 indicates that BMA is not too dependend on debt financing.

BMA has a Debt to Equity ratio of 0.12. This is in the better half of the industry: BMA outperforms 64.30% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.12
Debt/FCF	5.9
Altman-Z	N/A

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

		Industry Rank	Sector Rank
Current Ratio	N/A
Quick Ratio	N/A

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

BMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.84%, which is quite good.

BMA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 63.39% yearly.

BMA shows a strong growth in Revenue. In the last year, the Revenue has grown by 115.20%.

The Revenue has been growing by 110.09% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)8.84%

EPS 3Y79%

EPS 5Y63.39%

EPS Q2Q%-74.37%

Revenue 1Y (TTM)115.2%

Revenue growth 3Y130.21%

Revenue growth 5Y110.09%

Sales Q2Q%-12.02%

3.2 Future

The Earnings Per Share is expected to grow by 104.04% on average over the next years. This is a very strong growth

Based on estimates for the next years, BMA will show a small growth in Revenue. The Revenue will grow by 5.09% on average per year.

EPS Next Y188.12%

EPS Next 2Y104.04%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-3.64%

Revenue Next 2Y5.09%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

BMA's earnings are expected to grow with 104.04% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y104.04%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BMA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BANCO MACRO SA-ADR

NYSE:BMA (5/29/2025, 8:04:00 PM)

After market: 84.69 0 (0%)

84.69

-5.08 (-5.66%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupBanks

GICS IndustryBanks

Earnings (Last)05-22 2025-05-22

Earnings (Next)08-20 2025-08-20

Inst Owners34.99%

Inst Owner Change-12.71%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap5.32B

Analysts81.67

Price TargetN/A

Short Float %0.79%

Short Ratio0.5

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP71.76%

Div Incr Years2

Div Non Decr Years2

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)2

Avg Revenue beat(2)16.4%

Min Revenue beat(2)0.49%

Max Revenue beat(2)32.32%

Revenue beat(4)4

Avg Revenue beat(4)58.01%

Min Revenue beat(4)0.49%

Max Revenue beat(4)128.84%

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)-10.24%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-0.35%

Revenue NY rev (3m)-3.11%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)N/A

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpSN/A

BVpSN/A

TBVpSN/A

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	4.49%
ROE	16.07%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	9.66%
GM	N/A
FCFM	1.25%

ROA(3y)4.26%

ROA(5y)3.73%

ROE(3y)14.74%

ROE(5y)14.41%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-22.24%

PM growth 5Y-22.5%

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0.46

Health

		Industry Rank	Sector Rank
Debt/Equity	0.12
Debt/FCF	5.9
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	1.85%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	12.9%
Current Ratio	N/A
Quick Ratio	N/A
Altman-Z	N/A

F-Score3

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)3.11%

Cap/Sales(5y)3.07%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)8.84%

EPS 3Y79%

EPS 5Y63.39%

EPS Q2Q%-74.37%

EPS Next Y188.12%

EPS Next 2Y104.04%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)115.2%

Revenue growth 3Y130.21%

Revenue growth 5Y110.09%

Sales Q2Q%-12.02%

Revenue Next Year-3.64%

Revenue Next 2Y5.09%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1YN/A

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y104.2%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y110.74%

OCF growth 3YN/A

OCF growth 5YN/A

BANCO MACRO SA-ADR (BMA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens